Angela Dawson

MD, Obstetrician, Gynecologist


  • University of Kentucky, College of Medicine – Lexington, KY
  • Kentucky Wesleyan College – Owensboro, KY


  • Research Integrity, LLC – Owensboro, KY
  • The Women’s Pavillion, OB/GYN – Owensboro, KY



  • Central Association of Obstetricians and Gynecologists
  • American College of Obstetrics and Gynecology
  • Kentucky Medical Association
  • Daviess County Medical Association

Board Certification

Fellow: American Board of Obstetrician and Gynecologist


  • Kentucky License Number: 41041
  • Indiana License Number: 01065120A

See below for clinical research experience.

Clinical Research

  • An open-label, parallel-group.randomized, multicenter study to assess the safety and efficacy of vilaprisan in subjects with uterine fibroids versus standard of care. BAYER
  • Phase 3, randomized, double-blind, multicenter, placebo-controlled study evaluating the efficacy, safety and tolerability of elagolix alone and in combination with estradiol/norethindrone acetate for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women 18 to 51 years of age. MI2-815
  • Extension study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects with Moderate to Severe Endometriosis-Associated Pain. MI2-667
  • A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of Elagolix in subjects with moderate to serve endometriosis – associated pain. M12-66